[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545066":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":45,"collaborators":20,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":20,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":20,"enrollmentInfo":57,"targetDuration":20,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":67,"overallStatus":37,"whyStopped":20,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Rigshospitalet, Denmark","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"WARD equipment alarms","EXPERIMENTAL","alarms will notify the health personel that there is an abnormal vital sign, and the personel will act accordingly.",[13],"Device: WARD",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","WARD","Heart rate and respiratory rate is measured using Isansys lifetouch (Isansys Lifecare, Oxfordshire, UK), single-lead ECG monitor. An ECG is recorded as a 10-second segment every minute. Heart rate is derived once per minute from the R-R interval, and similarly, the RF is calculated from the changes in thoracic impedance once per minute. Blood pressure is monitored with either Meditech BlueBP-05 (Meditech Ltd., Budapest, Hungary) or A\\&D TM-2441 (A\\&D company Ltd., Tokyo, Japan). Both are non-invasive oscillometric, cuff-based blood pressure monitoring devices. Peripheral oxygen saturation was measured with NonIn WristOx 3150 (Nonin Medical Inc., Minnesota, USA) pulse oximeter, which is a photoplethysmograph with a sampling frequency of 75 Hz.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Sandra Egedie Lyby Taylor Pitter, MD","PRINCIPAL_INVESTIGATOR",[26,30],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},"CONTACT","+4540309153","sandra.egedie.taylor.pitter@regionh.dk",{"name":31,"role":27,"phone":32,"phoneExt":20,"email":33},"Eske K Aasvang, Professor","+4535450802","eske.kvanner.aasvang.01@regionh.dk",[35],{"facility":36,"status":37,"city":38,"state":20,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":20,"geoPoint":20,"contacts":42},"Rigshospitalet","RECRUITING","Copenhagen O","2100","Denmark","DK",[43],{"name":44,"role":27,"phone":28,"phoneExt":20,"email":29},"Sandra E L T Pitter, MD",{"type":24,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Sandra Taylor Pitter","MD","100545066","early-detection-of-complications-during-immunotherapy-for-haematological-malignancy-100545066",false,"NCT06377059","Early Detection of Complications During Immunotherapy for Haematological Malignancy","Early Detection of Complications During Immunotherapy for Haematological Malignancy - Description of Associated Vital Signs and Immune Responses","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Patients diagnosed with haematologic malignant disease (e.g. malignant lymphoma)\n* Patients scheduled for treatment with CART or BsAbs\n\nExclusion Criteria:\n\n* Patient is pregnant\n* Patient has a pacemaker\n* Patient is allergic to one or more of the materials that the equipment consists of\n* Investigator deems patient not able to comply with participation in the study","ALL","18 Years",{"count":58,"type":59},100,"ESTIMATED","INTERVENTIONAL",[62],"NA","Aims\n\n* To identify patients that should remain admitted in hospital for more intense surveillance because of high risk for development of clinical complications\n* Expand the understanding of the interactions between physiology and immunology for the design of future projects and general knowledge Hypothesis Development of a risk model based on a combination of physiological and immunological parameters can contribute to early detection of patients at risk for clinical complications after anti-cancer treatment.",[65,66],"Hematologic Cancer","CRS - Cytokine Release Syndrome",[68],"wireless monitoring","2026-05-12",{"date":71,"type":72},"2026-05-15","ACTUAL",{"date":74,"type":72},"2024-12-02",{"date":76,"type":59},"2027-07-01",{"name":5,"class":6},1]